News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
459,596 Results
Type
Article (21964)
Company Profile (71)
Press Release (437561)
Multimedia
Podcasts (18)
Webinars (7)
Section
Business (136860)
Career Advice (1337)
Deals (27274)
Drug Delivery (60)
Drug Development (53046)
Employer Resources (120)
FDA (10556)
Job Trends (10263)
News (231952)
Policy (22426)
Tag
Academia (1662)
Accelerated approval (5)
Adcomms (27)
Allergies (49)
Alliances (31540)
ALS (69)
Alzheimer's disease (1000)
Antibody-drug conjugate (ADC) (78)
Approvals (10557)
Artificial intelligence (171)
Autoimmune disease (17)
Automation (9)
Bankruptcy (222)
Best Places to Work (8596)
BIOSECURE Act (8)
Biosimilars (58)
Biotechnology (58)
Bladder cancer (68)
Brain cancer (18)
Breast cancer (231)
Cancer (1721)
Cardiovascular disease (133)
Career advice (1130)
Career pathing (16)
CAR-T (111)
Cell therapy (300)
Cervical cancer (14)
Clinical research (43594)
Collaboration (575)
Compensation (243)
Complete response letters (15)
COVID-19 (1821)
CRISPR (23)
C-suite (185)
Cystic fibrosis (83)
Data (1760)
Denatured (7)
Depression (24)
Diabetes (193)
Diagnostics (4649)
Digital health (9)
Diversity (3)
Diversity, equity & inclusion (29)
Drug discovery (81)
Drug pricing (72)
Drug shortages (17)
Duchenne muscular dystrophy (74)
Earnings (59473)
Editorial (29)
Employer branding (17)
Employer resources (106)
Events (69538)
Executive appointments (568)
FDA (11590)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (493)
Gene editing (61)
Generative AI (15)
Gene therapy (203)
GLP-1 (418)
Government (3598)
Grass and pollen (2)
Guidances (139)
Healthcare (13299)
Huntington's disease (15)
IgA nephropathy (16)
Immunology and inflammation (72)
Indications (24)
Infectious disease (1935)
Inflammatory bowel disease (88)
Inflation Reduction Act (5)
Influenza (42)
Intellectual property (58)
Interviews (175)
IPO (14348)
IRA (23)
Job creations (2041)
Job search strategy (989)
Kidney cancer (10)
Labor market (19)
Layoffs (260)
Leadership (13)
Legal (5081)
Liver cancer (51)
Lung cancer (237)
Lymphoma (121)
Machine learning (3)
Management (45)
Manufacturing (176)
MASH (57)
Medical device (9320)
Medtech (9323)
Mergers & acquisitions (13435)
Metabolic disorders (451)
Multiple sclerosis (60)
NASH (15)
Neurodegenerative disease (65)
Neuropsychiatric disorders (17)
Neuroscience (1381)
NextGen: Class of 2025 (4188)
Non-profit (3228)
Now hiring (5)
Obesity (210)
Opinion (156)
Ovarian cancer (68)
Pain (65)
Pancreatic cancer (62)
Parkinson's disease (103)
Partnered (17)
Patents (151)
Patient recruitment (81)
Peanut (30)
People (40861)
Pharmaceutical (21)
Pharmacy benefit managers (22)
Phase I (12634)
Phase II (19123)
Phase III (15422)
Pipeline (1115)
Policy (99)
Postmarket research (1686)
Preclinical (5461)
Press Release (69)
Prostate cancer (78)
Psychedelics (26)
Radiopharmaceuticals (184)
Rare diseases (287)
Real estate (3263)
Recruiting (47)
Regulatory (15361)
Reports (26)
Research institute (1419)
Resumes & cover letters (216)
Rett syndrome (5)
RNA editing (3)
RSV (27)
Schizophrenia (53)
Series A (70)
Series B (56)
Service/supplier (3)
Sickle cell disease (33)
Special edition (10)
Spinal muscular atrophy (112)
Sponsored (14)
Startups (2112)
State (1)
Stomach cancer (8)
Supply chain (38)
Tariffs (24)
The Weekly (10)
Vaccines (442)
Venture capitalists (25)
Weight loss (123)
Women's health (17)
Worklife (11)
Date
Last 7 days (694)
Last 30 days (2135)
Last 365 days (23189)
2025 (8349)
2024 (25392)
2023 (29158)
2022 (37806)
2021 (41012)
2020 (39512)
2019 (32544)
2018 (24568)
2017 (22275)
2016 (20575)
2015 (25049)
2014 (18753)
2013 (15043)
2012 (15942)
2011 (16479)
2010 (15209)
Location
Africa (517)
Alabama (42)
Alaska (6)
Arizona (120)
Arkansas (8)
Asia (25063)
Australia (4096)
California (4494)
Canada (1713)
China (354)
Colorado (194)
Connecticut (209)
Delaware (107)
Europe (58635)
Florida (664)
Georgia (131)
Idaho (34)
Illinois (359)
India (23)
Indiana (208)
Iowa (6)
Japan (142)
Kansas (77)
Kentucky (16)
Louisiana (10)
Maine (54)
Maryland (666)
Massachusetts (3221)
Michigan (137)
Minnesota (264)
Mississippi (2)
Missouri (73)
Montana (24)
Nebraska (19)
Nevada (58)
New Hampshire (57)
New Jersey (1354)
New Mexico (11)
New York (1331)
North Carolina (679)
North Dakota (5)
Northern California (2028)
Ohio (140)
Oklahoma (10)
Oregon (18)
Pennsylvania (986)
Puerto Rico (8)
Rhode Island (25)
South America (692)
South Carolina (17)
South Dakota (1)
Southern California (1673)
Tennessee (78)
Texas (649)
United States (16771)
Utah (120)
Virginia (106)
Washington D.C. (48)
Washington State (432)
West Virginia (3)
Wisconsin (48)
459,596 Results for "maps public benefit corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
MAPS Public Benefit Corporation Announces Oversubscribed Series A Financing and Renames to Lykos Therapeutics
MAPS Public Benefit Corp (“MAPS PBC”), a company dedicated to transforming mental healthcare, announced an oversubscribed Series A financing. MAPS PBC raised more than $100 million including conversion of previously issued convertible notes.
January 5, 2024
·
7 min read
BioMidwest
MMS Supported MAPS Public Benefit Corporation NDA Submitted to FDA for First Psychedelic-Assisted Therapy for PTSD
MMS announced MAPS Public Benefit Corporation (MAPS PBC) submitted a New Drug Application (NDA) to the FDA for MDMA (midomafetamine capsules) used in combination with psychological intervention, which includes psychotherapy, or talk therapy, and other supportive services provided by a qualified healthcare provider.
December 13, 2023
·
2 min read
Deals
BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal
In a move straight out of 2021, BridgeBio Oncology is taking the SPAC route to the public markets in a deal with Helix Acquisition Corp. II worth $450 million in proceeds.
February 28, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Can-Fite Innovative Publication: Namodenoson in Liver Cancer Treatment Alongside with Cardiac, Liver, and Neurological Benefits
March 4, 2025
·
6 min read
Press Releases
ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy
February 25, 2025
·
6 min read
Press Releases
Antengene Announces XPOVIO® Approved for Public Health Insurance Coverage in Taiwan Market, Benefiting More Patients with R/R MM in the Region
February 13, 2025
·
5 min read
Press Releases
AdaptHealth Corp. Announces First Quarter 2025 Results
May 6, 2025
·
17 min read
Press Releases
Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering
December 13, 2024
·
5 min read
Press Releases
180 Life Sciences Corp. Announces Share Repurchase
April 30, 2025
·
7 min read
Press Releases
Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering
December 9, 2024
·
5 min read
1 of 45,960
Next
